Broadly Neutralizing Antibody-Guided Carbohydrate-Based HIV Vaccine Design: Challenges and Opportunities
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Broadly Neutralizing Antibody-Guided Carbohydrate-Based HIV Vaccine Design: Challenges and Opportunities
Authors
Keywords
-
Journal
ChemMedChem
Volume 11, Issue 4, Pages 357-362
Publisher
Wiley
Online
2016-01-14
DOI
10.1002/cmdc.201500498
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Manipulating the Selection Forces during Affinity Maturation to Generate Cross-Reactive HIV Antibodies
- (2015) Shenshen Wang et al. CELL
- New approaches to HIV vaccine development
- (2015) Barton F Haynes CURRENT OPINION IN IMMUNOLOGY
- Designing synthetic vaccines for HIV
- (2015) Alberto Fernández-Tejada et al. Expert Review of Vaccines
- The HIV glycan shield as a target for broadly neutralizing antibodies
- (2015) Katie J. Doores FEBS Journal
- Single-injection vaccines: Progress, challenges, and opportunities
- (2015) Kevin J. McHugh et al. JOURNAL OF CONTROLLED RELEASE
- Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
- (2015) J. G. Jardine et al. SCIENCE
- HIV-1 neutralizing antibodies induced by native-like envelope trimers
- (2015) R. W. Sanders et al. SCIENCE
- Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
- (2015) Max Crispin et al. Current Opinion in Virology
- Recent progress in HIV vaccines inducing mucosal immune responses
- (2014) Vincent Pavot et al. AIDS
- Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers
- (2014) Emilia Falkowska et al. IMMUNITY
- High Temperature SELMA: Evolution of DNA-Supported Oligomannose Clusters Which Are Tightly Recognized by HIV bnAb 2G12
- (2014) J. Sebastian Temme et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface
- (2014) Jinghe Huang et al. NATURE
- Recent strategies targeting HIV glycans in vaccine design
- (2014) Satoru Horiya et al. Nature Chemical Biology
- Computational design of protein antigens that interact with the CDR H3 loop of HIV broadly neutralizing antibody 2F5
- (2014) M. L. Azoitei et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits
- (2014) Anila Yasmeen et al. Retrovirology
- Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection
- (2013) Peter Hraber et al. AIDS
- Directed Evolution of 2G12-Targeted Nonamannose Glycoclusters by SELMA
- (2013) J. Sebastian Temme et al. CHEMISTRY-A EUROPEAN JOURNAL
- Synthetic carbohydrate antigens for HIV vaccine design
- (2013) Lai-Xi Wang CURRENT OPINION IN CHEMICAL BIOLOGY
- Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
- (2013) Andrew T. McGuire et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Chemical Synthesis of Highly Congested gp120 V1V2 N-Glycopeptide Antigens for Potential HIV-1-Directed Vaccines
- (2013) Baptiste Aussedat et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
- (2013) Hua-Xin Liao et al. NATURE
- Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies
- (2013) Mohammed N Amin et al. Nature Chemical Biology
- Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
- (2013) Leopold Kong et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestors
- (2013) S. M. Alam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
- (2013) J. Jardine et al. SCIENCE
- A brief history of the global effort to develop a preventive HIV vaccine
- (2013) José Esparza VACCINE
- Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
- (2013) Sam Hoot et al. PLoS Pathogens
- A Blueprint for HIV Vaccine Discovery
- (2012) Dennis R. Burton et al. Cell Host & Microbe
- 2G12-Expressing B Cell Lines May Aid in HIV Carbohydrate Vaccine Design Strategies
- (2012) K. J. Doores et al. JOURNAL OF VIROLOGY
- Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
- (2012) Jinghe Huang et al. NATURE
- B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
- (2012) Barton F Haynes et al. NATURE BIOTECHNOLOGY
- Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape
- (2012) Penny L Moore et al. NATURE MEDICINE
- Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses
- (2012) D. R. Burton et al. SCIENCE
- Multivalent Glycocluster Design through Directed Evolution
- (2011) Iain S. MacPherson et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens
- (2011) Weizao Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Differential Reactivity of Germ Line Allelic Variants of a Broadly Neutralizing HIV-1 Antibody to a gp41 Fusion Intermediate Conformation
- (2011) S. M. Alam et al. JOURNAL OF VIROLOGY
- Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors
- (2011) M. Bonsignori et al. JOURNAL OF VIROLOGY
- Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
- (2011) Jason S. McLellan et al. NATURE
- Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
- (2011) Javier Guenaga et al. PLoS One
- The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade
- (2011) Camille Bonomelli et al. PLoS One
- Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold
- (2011) M. L. Azoitei et al. SCIENCE
- A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
- (2011) R. Pejchal et al. SCIENCE
- Envelope Deglycosylation Enhances Antigenicity of HIV-1 gp41 Epitopes for Both Broad Neutralizing Antibodies and Their Unmutated Ancestor Antibodies
- (2011) Ben-Jiang Ma et al. PLoS Pathogens
- Defining Criteria for Oligomannose Immunogens for HIV Using Icosahedral Virus Capsid Scaffolds
- (2010) Rena D. Astronomo et al. CHEMISTRY & BIOLOGY
- Antibody 2G12 Recognizes Di-Mannose Equivalently in Domain- and Nondomain-Exchanged Forms but Only Binds the HIV-1 Glycan Shield if Domain Exchanged
- (2010) Katie J. Doores et al. JOURNAL OF VIROLOGY
- Very Few Substitutions in a Germ Line Antibody Are Required To Initiate Significant Domain Exchange
- (2010) Michael Huber et al. JOURNAL OF VIROLOGY
- Variable Loop Glycan Dependency of the Broad and Potent HIV-1-Neutralizing Antibodies PG9 and PG16
- (2010) Katie J. Doores et al. JOURNAL OF VIROLOGY
- Scaffolding to build a rational vaccine design strategy
- (2010) D. R. Burton PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity
- (2010) K. J. Doores et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elicitation of structure-specific antibodies by epitope scaffolds
- (2010) G. Ofek et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens
- (2010) K. J. Doores et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
- (2010) X. Wu et al. SCIENCE
- Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine Epitope
- (2010) Bruno E. Correia et al. STRUCTURE
- Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens
- (2009) Xiaodong Xiao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
- (2009) L. M. Walker et al. SCIENCE
- A Glycoconjugate Antigen Based on the Recognition Motif of a Broadly Neutralizing Human Immunodeficiency Virus Antibody, 2G12, Is Immunogenic but Elicits Antibodies Unable To Bind to the Self Glycans of gp120
- (2008) R. D. Astronomo et al. JOURNAL OF VIROLOGY
- An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions
- (2008) J. G. Joyce et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN
- (2008) S.-K. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now